Renzo Poggio

Learn More
From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the following combination chemotherapy regimen:(More)
BACKGROUND Depression is one of the major contributors to the global burden of diseases; however, population-based data in South America are limited. METHODS We conducted a population-based cross(More)